2021
DOI: 10.3389/fonc.2021.708784
|View full text |Cite
|
Sign up to set email alerts
|

An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy

Abstract: PurposeAlthough the role of tumor-infiltrating T cells in follicular lymphoma (FL) has been reported previously, the prognostic value of peripheral blood T lymphocyte subsets has not been systematically assessed. Thus, we aim to incorporate T-cell subsets with clinical features to develop a predictive model of clinical outcome.MethodsWe retrospectively screened a total of 1,008 patients, including 252 newly diagnosed de novo FL patients with available peripheral blood T lymphocyte subsets who were randomized t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…T-lymphocyte subsets are detected as biomarkers for a patient's immune status in clinical practice, and prognostic values been reported in other subtypes of lymphoma. 5,6 The present study explored the potential role of T-lymphocyte subsets in MCL.…”
mentioning
confidence: 99%
“…T-lymphocyte subsets are detected as biomarkers for a patient's immune status in clinical practice, and prognostic values been reported in other subtypes of lymphoma. 5,6 The present study explored the potential role of T-lymphocyte subsets in MCL.…”
mentioning
confidence: 99%